Students' Knowledge and Views on Pharmacogenomic Education in the Medical Curriculum

Overview

Journal Indian J Pharmacol

Specialty Pharmacology

Date 2021 May 12

PMID 33975995

Citations 1

Authors

Manju Agrawal

Lopamudra Kirtania

Anuja Jha

Rajesh Hishikar

Affiliations

Soon will be listed here.

Abstract

Introduction: Pharmacogenomics is a growing field of science that explores the genetic contributions in an individual's response to the drug, so as to choose the right drug in the right doses tailored to a patient's genetic makeup. Although pharmacogenomics information is incorporated in chapters discussing relevant drugs, it has not been materialized into clinical practice yet and still, it remains a challenge due to limited knowledge and accessibility of the pharmacogenomic tests to diagnose these polymorphisms. With this background, the objective of the study was to assess the knowledge and perception of pharmacogenomics among second-year MBBS students and to sensitize them regarding pharmacogenomics.

Materials And Methods: A cross-sectional study was done in which 138 medical students responded to a preformed semi-structured assessment tool. It comprised two main components (1) knowledge and (2) relevance of pharmacogenomics in medical education and clinical practice.

Results: Ninety-five percent students defined pharmacogenomics correctly, but only 54% were aware of genetic variations in drug targets, metabolizing enzymes, and transporters affecting drug therapy. Only 15% knew about the availability of pharmacogenomics tests in India. Eighty-four percent of students felt that incorporating pharmacogenomics education in the MBBS curriculum is a must for precision medicine.

Conclusion: Second-year MBBS students had good knowledge of pharmacogenomics, but knowledge about the application in clinical practice and interpretation of pharmacogenomics was limited. Therefore, we recommend (1) basic pharmacogenomic education at all levels of medical curricula, (2) development of case-based knowledge application modules, (3) regular continuing medical education to update about available screening tools/biomarkers, and (4) patient and public awareness programs so that they receive personalized/precision medicine with optimum efficacy and reduced side effects and health-care costs.

Citing Articles

Development and Validation of the Minnesota Assessment of Pharmacogenomic Literacy (MAPL).

Allen J, Zhang L, Johnson A, Jacobson P, McCarty C, Pittenger A J Pers Med. 2022; 12(9).

PMID: 36143184 PMC: 9506235. DOI: 10.3390/jpm12091398.

References

McCullough K, Formea C, Berg K, Burzynski J, Cunningham J, Ou N . Assessment of the pharmacogenomics educational needs of pharmacists. Am J Pharm Educ. 2011; 75(3):51. PMC: 3109805. DOI: 10.5688/ajpe75351. View

Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck J . Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol. 2007; 128(1):35-44. DOI: 10.1038/sj.jid.5701033. View

Moen M, Lamba J . Assessment of healthcare students' views on pharmacogenomics at the University of Minnesota. Pharmacogenomics. 2012; 13(13):1537-45. PMC: 3562085. DOI: 10.2217/pgs.12.139. View

Haga S, Burke W . Using pharmacogenetics to improve drug safety and efficacy. JAMA. 2004; 291(23):2869-71. DOI: 10.1001/jama.291.23.2869. View

Aggarwal S, Phadke S . Medical genetics and genomic medicine in India: current status and opportunities ahead. Mol Genet Genomic Med. 2015; 3(3):160-71. PMC: 4444157. DOI: 10.1002/mgg3.150. View

Singh P, Agrawal M, Hishikar R, Joshi U, Maheshwari B, Halwai A . Adverse drug reactions at adverse drug reaction monitoring center in Raipur: Analysis of spontaneous reports during 1 year. Indian J Pharmacol. 2018; 49(6):432-437. PMC: 5892024. DOI: 10.4103/ijp.IJP_781_16. View

Ma Q, Lu A . Pharmacogenetics, pharmacogenomics, and individualized medicine. Pharmacol Rev. 2011; 63(2):437-59. DOI: 10.1124/pr.110.003533. View

Gurwitz D, Lunshof J, Dedoussis G, Flordellis C, Fuhr U, Kirchheiner J . Pharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools deans of education. Pharmacogenomics J. 2005; 5(4):221-5. DOI: 10.1038/sj.tpj.6500312. View

Formea C, Nicholson W, McCullough K, Berg K, Berg M, Cunningham J . Development and evaluation of a pharmacogenomics educational program for pharmacists. Am J Pharm Educ. 2013; 77(1):10. PMC: 3578323. DOI: 10.5688/ajpe77110. View

10.

Evans W . Pharmacogenetics of thiopurine S-methyltransferase and thiopurine therapy. Ther Drug Monit. 2004; 26(2):186-91. DOI: 10.1097/00007691-200404000-00018. View

11.

Mukherjee M, Colah R, Martin S, Ghosh K . Glucose-6-phosphate dehydrogenase (G6PD) deficiency among tribal populations of India - Country scenario. Indian J Med Res. 2015; 141(5):516-20. PMC: 4510748. DOI: 10.4103/0971-5916.159499. View

12.

Kudzi W, Addy B, Dzudzor B . Knowledge of Pharmacogenetics among Healthcare Professionals and Faculty Members of Health Training Institutions in Ghana. Ghana Med J. 2015; 49(1):50-6. PMC: 4549817. DOI: 10.4314/gmj.v49i1.9. View

13.

Higgs J, Andrews J, Gurwitz D, Payne K, Newman W . Pharmacogenetics education in British medical schools. Genomic Med. 2009; 2(3-4):101-5. PMC: 2694863. DOI: 10.1007/s11568-009-9032-6. View